Какова цена за Handa Pharmaceuticals, Inc. (6620)

Цена за Handa Pharmaceuticals, Inc. (6620) Это $2.95

Какова рыночная капитализация для Handa Pharmaceuticals, Inc. (6620)

Рыночная капитализация для Handa Pharmaceuticals, Inc. (6620) Это $491.95M

Handa Pharmaceuticals, Inc. (6620) Акции в обращении

Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.

Год	Акции в обращении	Изменить
Недостаточно данных для указанных дат.

Год

Акции в обращении

Изменить

Недостаточно данных для указанных дат.

Компания	Акции в обращении	Разница	Страна
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	2.40B	-	IN
Galderma Group AG GALD.SW	-	-	CH

Компания

Акции в обращении

Разница

Страна